Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIIb pilot trial of recombinant lysostaphin paint for deep partial-thickness burn wounds with MRSA infection
CTR20230948Phase 3Active
- Sponsor
- Shanghai High-tech United Biotechnology
- Start
- Sep 2023
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of staphylolysin in Staphylococcus aureus infection, burn wound infection, sponsored by Shanghai High-tech United Biotechnology. Started Sep 2023; status: active.
02
Drugs
staphylolysin
03
Conditions
Staphylococcus aureus infectionburn wound infection
Beyond the preview
Go deeper on CTR20230948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230948.